BLUEJAY DIAGNOSTICS INC (BJDX)
US0956333019 - Common Stock
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!
BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023
BJDX stock results show that Bluejay Diagnostics missed analyst estimates for earnings per share the fourth quarter of 2023.
BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bluejay Diagnostics (NASDAQ:BJDX) just reported results for the fourth quarter ...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for a breakdown of the biggest pre-market stock movers for Wednesday morning as we check out all of the latest news today!
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)
This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives. ACTON,...
Bluejay Diagnostics files to sell common stocks, warrants (NASDAQ:BJDX)
Bluejay Diagnostics (BJDX) has filed a prospectus for the offer and sale of common stocks and warrants.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!
Bluejay Diagnostics to raise $1.59M to fund FDA approval process (NASDAQ:BJDX)
Medical technology company Bluejay Diagnostics (BJDX) Friday said it entered into a deal for the purchase and sale of 216,000 of its shares for $7.365 per share.In addition, in...
Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
ACTON, Mass., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results
ACTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...
Bluejay Diagnostics regains compliance with Nasdaq listing standards (NASDAQ:BJDX)
Bluejay Diagnostics Inc (BJDX) Friday announced it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule